Amendment sought to prohibit the State Department from imposing restrictions on any intellectual property law or policy of any country in Africa or Asia, including Israel, that is designed to make pharmaceuticals more affordable, if such law or policy complies with the Agreement on Trade-Related Aspects of Intellectual Property Rights.

Ask AI
Amendment Number
322
Description
Amendment sought to prohibit the State Department from imposing restrictions on any intellectual property law or policy of any country in Africa or Asia, including Israel, that is designed to make pharmaceuticals more affordable, if such law or policy complies with the Agreement on Trade-Related Aspects of Intellectual Property Rights.
Purpose
An amendment, no. 15, printed in Part B, H.Rept. 106-235 to prohibit the State Department from imposing restrictions on any intellectual property law or policy of any country in Africa or Asia, including Israel, that is designed to make pharmaceuticals more affordable, if the law or policy complies with the Agreement on Trade-Related Aspects of Intellectual Property Rights.
Congress
106
Type
HAMDT
Latest Action Date
Jul 21, 1999
Latest Action Text
On agreeing to the Sanders amendment (A009) Failed by recorded vote: 117 - 307 (Roll no. 322).
Latest Action Time
12:47:24
Submitted Date
Jul 21, 1999
Chamber
House of Representatives
Update Date
Aug 15, 2021
Amendment 322 — Informed